| |
| |
|
| Insider
Information: |
Trieu Vuong |
| Relationship: |
CHAIRMAN AND CEO, Dire... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
95,663,574 |
|
|
Indirect Shares
|
26,577,010 |
|
|
| Direct
Value |
$23,964,569 |
|
|
|
Indirect Value
|
$6,149,757 |
|
|
| Total
Shares |
122,240,584 |
|
|
| Total
Value |
$30,114,327 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 36.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sorrento Therapeutics Inc |
SRNE |
Officer, Director |
2013-09-09 |
3,006,641 |
|
0 |
Premium* |
|
|
Adhera Therapeutics, Inc |
ATRX |
Director, 10% Owner |
2018-10-01 |
612,716 |
2018-10-01 |
2,924,097 |
Premium* |
|
|
Mateon Therapeutics Inc |
MATN |
CHAIRMAN AND CEO, Dire... |
2023-06-29 |
92,044,217 |
2023-06-29 |
23,652,913 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2023-06-29 |
4 |
B |
$0.02 |
$8,925 |
D/D |
425,000 |
92,044,217 |
3.15 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2023-06-28 |
4 |
B |
$0.03 |
$1,950 |
D/D |
75,000 |
91,619,217 |
3.15 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2023-06-14 |
4 |
B |
$0.03 |
$13,040 |
D/D |
400,000 |
91,444,217 |
3.15 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2023-05-26 |
4 |
B |
$0.03 |
$4,327 |
D/D |
126,888 |
91,044,217 |
3.15 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2023-05-02 |
4 |
B |
$0.05 |
$4,500 |
D/D |
100,000 |
90,917,329 |
3.15 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2022-12-06 |
4 |
B |
$0.05 |
$6,000 |
D/D |
120,000 |
90,558,021 |
3.15 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2022-09-26 |
4 |
B |
$0.07 |
$1,360 |
D/D |
20,000 |
90,368,021 |
3.15 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2022-08-25 |
4 |
B |
$0.08 |
$6,560 |
D/D |
80,000 |
90,348,021 |
3.15 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2021-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
259,302 |
90,527,323 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
I/I |
19,521,186 |
6,872,529 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHAIRMAN AND CEO |
• • • |
2021-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
74,455,719 |
90,268,021 |
0 |
- |
|
| MATN |
Mateon Therapeutics Inc |
CHIEF EXECUTIVE OFFICER |
• – – |
2020-11-19 |
4 |
B |
$0.19 |
$9,595 |
D/D |
50,500 |
15,812,308 |
2.74 |
% |
|
| MATN |
Mateon Therapeutics Inc |
CHIEF EXECUTIVE OFFICER |
• – – |
2020-03-26 |
4 |
B |
$0.12 |
$360 |
D/D |
3,000 |
15,761,808 |
0.01 |
% |
|
| MATN |
Mateon Therapeutics Inc |
CEO and Chairman of the BoardO |
• • • |
2019-04-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,131,727 |
|
- |
|
| MATN |
Mateon Therapeutics Inc |
CEO and Chairman of the BoardO |
• • • |
2019-04-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,758,808 |
|
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Director |
– • • |
2018-10-01 |
4 |
D |
$0.50 |
$250,000 |
D/D |
(500,000) |
612,716 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Chairman of the Board |
• • • |
2017-06-09 |
4 |
B |
$0.39 |
$3,900 |
D/D |
10,000 |
11,127,141 |
3.15 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Chairman of the Board |
• • • |
2017-06-08 |
4 |
B |
$0.39 |
$7,800 |
D/D |
20,000 |
11,117,141 |
3.15 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Chairman of the Board |
• • • |
2017-06-07 |
4 |
B |
$0.38 |
$950 |
D/D |
2,500 |
11,097,141 |
3.15 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Chairman of the Board |
• • • |
2016-11-15 |
4 |
A |
$0.00 |
$0 |
I/I |
28,378,912 |
5,255,354 |
0 |
- |
|
| ATRX |
Adhera Therapeutics, Inc |
Chairman of the Board |
• • • |
2016-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,094,641 |
11,094,641 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Chief Scientific OfficerOffice |
• • – |
2013-09-09 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,006,641 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
